- Bennett to Announce New Growth Model
- State Reaches Settlement With CVS
- Deadline Nearing For National Idea to Product Contest
- DNR to Close Southern Indiana Campground
- Haynes Reports Q1 Loss
- IU Kokomo Narrows List of Chancellor Candidates
- MISCOR Sells Two Businesses
- Randolph County Dairy Files For Bankruptcy
- [UPDATED] ExactTarget Lands More High Profile Clients
updated: 7/17/2008 11:22:57 AM
Merck Funds HPV Research at Kelley School
Pharmaceutical manufacturer Merck and Co. (NYSE:MRK) has awarded two Indiana University Kelley School of Business professors a $79,000 research grant to study the effect of two interventions on acceptance of the HPV (human papillomavirus) vaccination among low-income and minority women. HPV is the virus that causes cervical cancer. Professor Dena Cox will focus on how consumers make health care decisions and co-investigator, professor Anthony Cox, will study how consumers evaluate risk in making medical treatment decisions.
Source: Inside INdiana Business
 Phil Ray, Omni Severin Indianapolis, General ManagerOmni Severin Indianapolis General Manager Phil Ray talks to Inside INdia... |
 Jonathan Weinzapfel, Mayor of EvansvilleIn a Studio(i) interview with Inside INdiana Business Host Gerry Dick, W... |
 Mike Peduto, Partner, Circle City TicketsIn a Studio(i) interview, Peduto talked about the demand for Colts ticke... |
FrontPg.jpg)
Press Release
INDIANAPOLIS, July 17, 2008 – Two Kelley School of Business Indianapolis professors were recently awarded a $79,000 research grant by pharmaceutical giant Merck and Company. The co-investigators, Eli Lilly Fellow Dena Cox and Chancellor’s Fellow Anthony D. Cox, both professors of marketing at the Kelley School of Business Indianapolis, will conduct a two-year study examining the effect of two interventions on acceptance of the HPV (human papillomavirus) vaccination among low-income and minority women. HPV is the virus that causes cervical cancer.
Dena Cox, the principal investigator on the study, had a previous career as a microbiologist before receiving a Ph.D. in marketing from the University of Houston. Her research focuses on how consumers make health care decisions. Co-investigator Anthony Cox, who earned his Ph.D. in marketing from Indiana University, studies how consumers evaluate risk in making medical treatment decisions. Their collaborative research has been funded by numerous external grants, and has appeared in top journals in both business and medicine.
HPV is a sexually-transmitted virus that plays a key role in the development of cervical cancer. HPV vaccination of young women and girls has been shown to reduce their lifetime risk of cervical cancer by as much as 70%. The HPV vaccine is expected to be an especially important tool in reducing cervical cancer among low income and minority women, since these women are often less likely to receive regular cervical cancer screening. Thus, the research will seek the most effective ways to present HPV vaccine risk and benefit information to low-income Hispanic, African-American and White women, so that they can make informed HPV vaccination decisions.
About Kelley School of Business at Indianapolis
The IU Kelley School of Business has been a leader in American business education for more than 80 years. With an enrollment of more than 4,800 undergraduate and nearly 2,000 graduate students, it is among the premier business schools in the country. Kelley’s Indianapolis campus, based at IUPUI, is home to the school’s Evening MBA and Master of Science in Accounting programs and a full-time undergraduate program.
Source: IU Kelley School of Business
